Preclinical efficacy of the bioreductive alkylating agent RH1 against paediatric tumours

Journal article

Open access

Peer reviewed

D Hussein, S V Holt, K E Brookes, T Klymenko, J K Adamski, A Hogg, E J Estlin, T Ward, C Dive and G W J Makin

British journal of cancer, Vol.101(1), pp.55-63

07/07/2009

PMCID: PMC2713707

PMID: 19491903

Abstract

childhood cancer

Ewing's sarcoma

neuroblastoma

novel therapies

osteosarcoma

Translational Therapeutics

url

https://doi.org/10.1038/sj.bjc.6605100View

Published (Version of record) Open

7 Record Views

Title: Preclinical efficacy of the bioreductive alkylating agent RH1 against paediatric tumours
Creators - without role: D Hussein - Cancer Research UK Manchester Institute
S V Holt - Cancer Research UK Manchester Institute
K E Brookes - Cancer Research UK Manchester Institute
T Klymenko - Cancer Research UK Manchester Institute
J K Adamski - Cancer Research UK Manchester Institute
A Hogg - Cancer Research UK Manchester Institute
E J Estlin - Royal Manchester Children's Hospital
T Ward - Cancer Research UK Manchester Institute
C Dive - Cancer Research UK Manchester Institute
G W J Makin - University of Manchester
Publication Details: British journal of cancer, Vol.101(1), pp.55-63
Publisher: Nature Publishing Group
Identifiers: 9937541408331
Academic Unit: King Abdulaziz University
Language: English
Resource Type: Journal article